The orbitofrontal cortex (OFC) is critical to identifying task structure and to generalizing appropriately across task states with similar underlying or hidden causes. This capability is at the heart ...
The Bermuda Triangle may not be the biggest mystery of the Atlantic. In a new study published in the journal Geophysical Research Letters, scientists believe they have discovered the reason why ...
Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...
After weeks of what had been tightly buttoned talks between the parties, Senate Democrats have delivered their latest counteroffer on the crypto market structure bill, outlining a set of demands ...
Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Structure Therapeutics ...
As Sucrose is a 4-Star Character, there is a small chance of unlocking them through the normal banner, but if the following banners are active, there is a higher chance of unlocking the character: ...
Two enormous structures that sit at the border between the Earth’s mantle and its core have puzzled scientists for decades, defying reigning theories of how our planet came to be. In a new study ...
Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches Strengthens US supply of ...
Health and Human Services Secretary Robert F. Kennedy, Jr., cheered Tyson Foods Company’s decision to drop high fructose corn syrup (HFCS) from its branded products by the end of this year. However, ...
Viatris (NASDAQ:VTRS) announced on Monday that the U.S. FDA has approved its Iron Sucrose Injection, USP, as a generic product targeting Venofer marketed by Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) ...
Viatris and Amphastar Pharmaceuticals both received Food and Drug Administration approval of generic iron sucrose injection products for the treatment of iron deficiency anemia in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback